Vote in the European Parliament

Laying a framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest, and amending Regulation (EU) 2024/795

Date: 20.01.2026·Reference: A10-0272/2025
Rapporteur: Tomislav Sokol
For227
  • 227 For
  • 299 Against
  • 138 Abstention
  • 55 Did not vote
Amendment— You are viewing a sub-vote (amendment) of the main vote.
← Back to Main Vote

Status

Rejected

Outcome as recorded by the European Parliament.

Vote held on

Procedure timeline

No procedure timeline is available for this vote yet.

Sources

Data: EP Open Data API

What is this about?

P10_PV(2026)01-20(RCV)

  • This regulation seeks to enhance the security of supply and availability of critical medicines across the EU.
  • It establishes a framework to diversify supply chains and incentivize investments in local manufacturing capacities.
  • Special focus is placed on older, off-patent drugs through targeted financial support and streamlined approval processes.
  • Coordination among member states aims to reduce market fragmentation and strengthen the internal market.
  • The goal is to bolster the EU’s strategic autonomy in the healthcare sector.
Source: Explanatory Statement (AI Generated)

Vote by political group

How the political groups voted

Members

Showing 10 of 719

Vote Position
NameCountryGroupVote Position
GreeceNI
For
ItalyGreens/EFA
For
RomaniaRenew
For
FranceRenew
For
ItalyGUE/NGL
For
BulgariaRenew
For
GreeceS&D
For
NetherlandsRenew
For
DenmarkGreens/EFA
For
SwedenS&D
For
Show more
Follow us on Instagram@checksomevotes@checksomevotes_en